V DEADLINE TOMORROW: ROSEN, A GLOBALLY RECOGNIZED LAW FIRM, Encourages Visa Inc. Investors to Secure Counsel Before Important January 21 Deadline in Securities Class Action First Filed by the Firm – V

(NYSE:V), NEW YORK, Jan. 20, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Visa Inc. (NYSE: V) between November 16, 2023 and September 23, 2024, both dates inclusive (the “Class Period”), of the important January 21, 2025 lead plaintiff deadline in the securities class […]

ASP Isotopes, Inc. Class Action Lawsuit Alert: Johnson Fistel Announces Shareholders with Losses Should Contact the Law Firm for More Information

Johnson Fistel, LLPannouncesthat a class action lawsuit has commenced on behalf of investors of ASP Isotopes Inc. (NASDAQ: ASPI). The lawsuit seeks to recover losses on behalf of investors who acquired securities between October 30, 2024 and November 26, 2024. Investors have until February 3, 2025, to apply to the Court to be appointed as

PMP Parking Lot Striping & Sealcoating: Leading Paving Contractor Revolutionizing Parking Lot Maintenance in Royse City, TX

Royse City, TX – PMP Parking Lot Striping & Sealcoating offers high-quality solutions tailored to meet the diverse needs of businesses in Royse City, TX. With expertise in parking lot striping, sealcoating, and designating spaces for parking or restricted zones, the company provides seamless services to commercial properties, enhancing safety, organization, and curb appeal. A

Dentsply Sirona Inc. Sued for Securities Law Violations – Contact Levi & Korsinsky Before January 27, 2025 to Discuss Your Rights – XRAY

NEW YORK, NY / ACCESSWIRE / January 20, 2025 / If you suffered a loss on your Dentsply Sirona Inc. (NASDAQ:XRAY) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/dentsply-lawsuit-submission-form?prid=123949&wire=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call

Shareholders that Lost Money on Marqeta, Inc. (MQ) Should Contact Levi & Korsinsky About Pending Class Action – MQ

NEW YORK CITY, NY / ACCESS Newswire / January 20, 2025 / If you suffered a loss on your Marqeta, Inc. (NASDAQ:MQ) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/marqeta-inc-lawsuit-submission-form?prid=123945&wire=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or

Kyverna Therapeutics, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before February 7, 2025 to Discuss Your Rights – KYTX

NEW YORK CITY, NY / ACCESS Newswire / January 20, 2025 / If you suffered a loss on your Kyverna Therapeutics, Inc. (NASDAQ:KYTX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/kyverna-therapeutics-inc-lawsuit-submission-form?prid=123944&wire=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com

Investors in Customers Bancorp, Inc. Should Contact Levi & Korsinsky Before January 31, 2025 to Discuss Your Rights – CUBI

NEW YORK CITY, NY / ACCESS Newswire / January 20, 2025 / NEW YORK, NY / ACCESSWIRE / January 20, 2025 / If you suffered a loss on your Customers Bancorp, Inc. (NYSE:CUBI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/customers-bancorp-inc-lawsuit-submission-form?prid=123943&wire=1

InventHelp Inventors Develop Improved Pet Kennel (CSK-667)

“We wanted to create an improved pet kennel that would be constructed from upgraded materials for more durable outdoor use,” said one of two inventors, from Buffalo,S.C., “so we invented the DAVIS KENNELS. Our design would eliminate the need for chains or leads, and it would keep pets cool and cozy while outdoors.” https://mma.prnewswire.com/media/2099578/InventHelp_Logo_jpg_Logo.jpg The

Regeneron Pharmaceuticals (REGN) Faces Securities Class Action After Losing $9 Billion Value Following Q3 2024 Earnings Report – Hagens Berman

(NASDAQ:REGN), SAN FRANCISCO, Jan. 20, 2025 (GLOBE NEWSWIRE) — Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) faces a securities fraud class action after shares of the company plunged $84.59 on Oct. 31, 2024, wiping out about $9 billion of market value. Hagens Berman has opened an investigation into whether Regeneron may have misled investors about its marketing

Scroll to Top